|Bid||34.08 x 13500|
|Ask||34.09 x 3500|
|Day's Range||34.00 - 34.22|
|52 Week Range||29.83 - 37.39|
|PE Ratio (TTM)||28.69|
|Dividend & Yield||1.28 (3.78%)|
|1y Target Est||N/A|
Tenet Healthcare Corp. (NYSE:THC) was up 6.9% on the day; Community Health Systems (NYSE:CYH) was up 5.1%; HCA Healthcare Inc (NYSE:HCA) was up 2.1% and gained another dime per share overnight. UnitedHealth Group Inc (NYSE:UNH) hit an all-time high, adding almost $3 billion to its market cap. Hospitals like Tenet were rallying employees against this bill, because they know that.
The main headwind for Regeneron is that Swiss pharma giant Novartis could soon be a rival to the eye drug that drives most of Regeneron's revenue.
Vertex (VRTX) has planned to submit a new drug application to the FDA in 3Q17 for a Tezacaftor-Ivacaftor combination treatment for cystic fibrosis.